Blog

Hospira gets FDA warning letter for Italian facility

(Reuters) – Hospira Inc, which agreed in February to be acquired by Pfizer Inc, said it received a warning letter from the U.S. Food and Drug Administration related to its manufacturing facility in Liscate, Italy. The letter, received on April 1, does not restrict the production or shipment of Hospira’s pharmaceutical products from the facility, the company said on Tuesday. (http://1.usa.gov/1Pg9wst) (Reporting by Natalie Grover in Bengaluru; Editing by Sriraj

U.S. FDA staff: Swedish Match snus proposal raises questions

(Reuters) – A preliminary review by the U.S. Food and Drug Administration raised “concerns” as to whether Swedish Match AB’s proposed change to warnings on its snus smokeless tobacco products adequately reflect the health risk. The review released on Tuesday also raised questions as to whether the positive impact of snus on smoking rates in Sweden would also be seen in the United States if the agency grants the company’s

Sustainability should not be about selling one more handbag: Kering CEO

Half of Gucci’s leather handbags are produced with more sustainable tanning NEW YORK – Rather than being a constraint, sustainability is an opportunity for companies to create value for their stakeholders, said the CEO of Kering at Parsons The New School for Design’s “Kering Talk: Why Sustainable Fashion is Smart Business?” on April 2. Instead of looking at ecologically friendly efforts as a marketing strategy or a selling point, Kering